Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...

High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and ...

Orange County Mayor Jerry Demings recently revealed that he is battling prostate cancer, the second-most common cancer for ...

Just two days after his minimally invasive prostate cancer treatment at NYU Langone Health, Broadway performer André De ...

High-risk localized and locally advanced prostate cancer patients treated with apalutamide - a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) - plus hormone therapy before and ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...